InsiderTrades

Form 4 for NEO NEOGENOMICS INC

Accepted 2022-03-03 00:00:00 ET · period of report 2022-03-01 · accession 0001077183-22-000040 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2022-03-03 2022-03-01+ NEO Bonello William CFO F - Tax $0.00 -1,017 101.7K -1.0% $0
D 2022-03-03 2022-03-01 NEO Bonello William CFO A - Grant $0.00 +40.9K 102.7K +66% $0
D 2022-03-03 2022-03-01 NEO Bonello William CFO A - Grant $0.00 +99.8K 99.8K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-03-01 F D 397 $0.00 102,345 D — — (F2) Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 1, 2022 vesting of restricted stock.
2 Common Common Stock 2022-03-01 A A 40,869 $0.00 102,742 D — — (F1) On March 1, 2022, Mr. Bonello was granted 40,869 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date.
3 Common Common Stock 2022-03-02 F D 620 $0.00 101,725 D — — (F3) Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 2, 2022 vesting of restricted stock.
4 Derivative Stock Option (Right to Buy) 2022-03-01 A A 99,772 $0.00 99,772 D $21.41 · — to 2029-03-01 99,772 Common Stock (F9) On March 1, 2022, Mr. Bonello was granted 99,772 stock options. These options vest ratably over the first four anniversary dates of the grant date.